Reddit Stock Slips Nearly 6 After Meta Launches Standalone Forum App BofA Increases Philip Morris International Price Target by 9 Cites Strong Outlook Standard Chartered Plans to Cut Over 15 of Corporate Functions Roles Targets Higher Returns by 2028 Anesthesiologist Assistant Prioritizes WorkLife Balance Over Potential 500K Income The Pothole Puzzle Britains 186bn Road Repair Backlog and Its Economic Impact US Consumer Sentiment Remains Pessimistic Amid Inflation and Trade Policy Concerns HSDT Q1 2026 Earnings Significant EPS Miss Raises Concerns CALC Q1 2026 Earnings Surprising Profit on a PerShare Basis Yet Shares Decline FNWD Q1 2026 Earnings EPS Miss Slightly as Stock Nudges Higher ADUS Q1 2026 Earnings EPS Beats Estimates by 242 Stock Edges Higher CWAN Q1 2026 Earnings EPS Misses Estimates by a Narrow Margin Coastal Financial Corporation Q1 2026 Earnings EPS Misses Estimates by 261 as Stock Declines United Microelectronics UMC Surges 1575 on Strong Momentum Key Levels to Watch MasTec Inc MTZ Rises 173 as Infrastructure and Energy Tailwinds Support Momentum Viking Holdings VIK Edges Higher as Stock Consolidates Near Key Levels UnitedGuardian Inc UG Slides 113 as Stock Tests Key Support Zone OYSE Holds Steady at 1028 SPAC Shows Minimal Price Movement SpaceX Successfully Launches Starship on Second Attempt Advancing DeepSpace Ambitions GRI Bio Inc Q1 2026 Earnings EPS Misses Estimates as DevelopmentStage Company Faces Headwinds Ionis Pharmaceuticals IONS Edges Higher as Biotech Sector Holds Steady Federal Reserve Governor Miran Resigns Endorses Warsh as Next Chair DDS Q1 2026 Earnings EPS Misses Estimates Shares Rise on Resilient Performance Coatues Philippe Laffont Bets on Hertz as Golden Cross Emerges Versamet Royalties Corporation VMET Q1 2026 Earnings Massive EPS Beat Boosts Investor Sentiment SLXN Q1 2026 Earnings NarrowerThanExpected Loss Drives Surprise but Stock Declines ExLabour Adviser Warns Schools Are Pipeline to Joblessness for UK Youth Urges Social Media Ban and Education Reform PTHS Q1 2026 Earnings Pelthos Therapeutics Surprises with NarrowerThanExpected Loss in Q1 2026